|
|
|
|
|
| Academic Network Ranks No. 2,526 on the 2008 Inc. 5,000, No. 40 in the Portland Metro Region with Three-Year Sales Growth of 141% |
|
|
| In a series of upcoming events, KnujOn.com will be discussing a plan to eradicate fake pharmacies and other illicit traffic from the Internet. |
|
|
| Phoenix Data Systems (PDS), a subsidiary of Bio-Imaging Technologies (NASDAQ:BITI) and global provider of clinical data services including electronic data capture (EDC) and comprehensive eClinical data solutions, today announced industry veteran Chris Connor has been appointed to the newly created position of director of product development. In this position, Connor will guide the software development roadmap for PDS’ Express suite of eClinical technology products. |
|
|
| OpenClinica 2.5 represents a significant milestone for the growing open source clincial trials software. This release contains a host of improvements particularly oriented towards the needs of regulated industry sponsored clinical trials. |
|
|
| At work, at home and in relationships, new survey findings point to ADHD challenges in adults |
|
|
| Projects include early-stage clinical trials, registries, and investigator-initiated grant management programs |
|
|
| Artcraft Pharma and Anatstat Health Education are proud to announce that effective September 15, 2008, they have merged, creating Artcraft Health Education. |
|
|
| Health plans and employers increasingly are turning to audits to ensure that their PBMs are delivering on contractual promises. |
|
|
| Carroll Publishing, the nation’s leader in federal, state and local government contact information for over 35 years, today announced the largest ever redesign of their proprietary GovSearchTM line of products, capping a two-year programming effort. |
|
|
| After six years of presenting DAM Briefings in New York, Los Angeles, London, England and mainland Europe, Henry Stewart Events is bringing this content packed briefing to Atlanta. One full day devoted to the problems and solutions encountered in this increasingly important corporate activity. |
|
|
